Your browser doesn't support javascript.
loading
Fertility-sparing surgery and survival among reproductive-age women with epithelial ovarian cancer in 2 cancer registries.
Crafton, Sarah M; Cohn, David E; Llamocca, Elyse N; Louden, Elaine; Rhoades, Jennifer; Felix, Ashley S.
Afiliación
  • Crafton SM; Division of Gynecologic Oncology, Allegheny Health Network, Pittsburgh, Pennsylvania.
  • Cohn DE; Division of Gynecologic Oncology, Ohio State University College of Medicine, Columbus, Ohio.
  • Llamocca EN; Division of Epidemiology, Ohio State University College of Public Health, Columbus, Ohio.
  • Louden E; Division of Epidemiology, Ohio State University College of Public Health, Columbus, Ohio.
  • Rhoades J; Division of Epidemiology, Ohio State University College of Public Health, Columbus, Ohio.
  • Felix AS; Division of Epidemiology, Ohio State University College of Public Health, Columbus, Ohio.
Cancer ; 126(6): 1217-1224, 2020 03 15.
Article en En | MEDLINE | ID: mdl-31774553
BACKGROUND: This study examined predictors of fertility-sparing surgery (FSS) among reproductive-age women diagnosed with epithelial ovarian cancer (EOC). In addition, relationships between FSS and survival were assessed in models stratified by tumor characteristics. METHODS: The Surveillance, Epidemiology, and End Results (SEER) program and the National Cancer Database (NCDB) were queried for women 44 years old or younger with a primary EOC. FSS included unilateral salpingo-oophorectomy and uterine preservation, whereas surgeries including bilateral salpingo-oophorectomy and hysterectomy were categorized as non-FSS. Logistic regression was used to estimate multivariable-adjusted odds ratios and 95% confidence intervals (CIs) for associations between clinical characteristics (eg, age at diagnosis and race) and FSS odds. Multivariable Cox regression was used to estimate hazard ratios (HRs) and 95% CIs for FSS and overall survival in subgroups defined by stage and grade or by stage and histology. Analyses were stratified by database (SEER vs NCDB). RESULTS: This analysis included 9017 women (SEER, n = 3932; NCDB, n = 5085) with EOC diagnosed between the ages of 15 and 44 years. In both cohorts, factors associated with significantly higher FSS odds included a younger age, a more recent ovarian cancer diagnosis, and no adjuvant chemotherapy. FSS was significantly associated with lower overall survival among women with stage II to IV, serous EOC (SEER HR, 1.61; 95% CI, 1.22-2.12). Significant associations between FSS and survival were not observed in other subgroups defined by stage and grade or by stage and histology. CONCLUSIONS: FSS appears to be safe for certain women with EOC but was related to poor survival among women with advanced-stage, serous EOC. Confirmatory studies with information on fertility intentions are needed.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Preservación de la Fertilidad / Carcinoma Epitelial de Ovario Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Female / Humans Idioma: En Revista: Cancer Año: 2020 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Preservación de la Fertilidad / Carcinoma Epitelial de Ovario Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Female / Humans Idioma: En Revista: Cancer Año: 2020 Tipo del documento: Article Pais de publicación: Estados Unidos